examines why a "large supply" of pediatric antiretroviral (ARV) drugs in Uganda might expire and go unused. "Fewer than a quarter of the 125,000 Ugandan children who need life-prolonging [ARVs] have access to it, mainly because of stigma and inadequate education of parents, say specialists," IRIN reports (9/10).
Back to other news for September 2009
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.